Transvaginale hormonelle Kontrazeption: Der NuvaRing^®

ISSN： 0017-5994

Source： Der Gynäkologe, Vol.39, Iss.9, 2006-09, pp. : 712-716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Hormonelle Kontrazeption

By Rabe T. Strowitzki T.

Gynäkologische Endokrinologie, Vol. 11, Iss. 3, 2013-09 ,pp. : 161-161

Springer Publishing Company

Access to resources Recommend Favorite

Intrauterine hormonelle Kontrazeption

By Römer T. Bühling K.J.

Gynäkologische Endokrinologie, Vol. 11, Iss. 3, 2013-09 ,pp. : 188-196

Springer Publishing Company

Access to resources Recommend Favorite

Hormonelle Kontrazeption mit östradiolhaltigen Kombinationspräparaten

By Foth D. Römer T. Ahrendt H.-J.

Gynäkologische Endokrinologie, Vol. 11, Iss. 3, 2013-09 ,pp. : 162-167

Springer Publishing Company

Access to resources Recommend Favorite

Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition

By Mulders T.M.T. Dieben T.O.M.

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 865-870

Elsevier

Access to resources Recommend Favorite

The contraceptive vaginal ring, NuvaRing^®, a decade after its introduction

By Roumen Frans J. M. E. Mishell Daniel R.

The European Journal of Contraception and Reproductive Health Care, Vol. 17, Iss. 6, 2012-12 ,pp. : 415-427

Informa Healthcare

Access to resources Recommend Favorite